PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

By Djavan B.   Zlotta A.   Kratzik C.   Remzi M.   Seitz C.   Schulman C.C.   Marberger M.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 517-522

Elsevier

Access to resources Recommend Favorite

Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/mL

By Ito K.   Yamamoto T.   Ohi M.   Kurokawa K.   Suzuki K.   Yamanaka H.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 760-764

Elsevier

Access to resources Recommend Favorite

Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysis

By Sokoll L.J.   Chan D.W.   Mikolajczyk S.D.   Rittenhouse H.G.   Evans C.L.   Linton H.J.   Mangold L.A.   Mohr P.   Bartsch G.   Klocker H.   Horninger W.   Partin A.W.  

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 274-276

Elsevier

Access to resources Recommend Favorite

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

By Catalona W.J.   Partin A.W.   Finlay J.A.   Chan D.W.   Rittenhouse H.G.   Wolfert R.L.   Woodrum D.L.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite

Diagnostic Significance of PSA Density Adjusted by Transition Zone Volume in Males with PSA Levels between 2 and 4ng/ml

By Ohi M.   Ito K.   Suzuki K.   Yamamoto T.   Yamanaka H.  

European Urology, Vol. 45, Iss. 1, 2004-01 ,pp. : 92-97

Elsevier

Access to resources Recommend Favorite